Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clear all

875 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200020
200131
200220
200321
200425
200540
200638
200742
200837
200941
201039
201133
201241
201344
201443
201529
201638
201728
201831
201925
202022
202129
202224
202317
202427
202516
202622

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed475
Terminated140
Unknown status82
Recruiting70
Active, not recruiting38
Withdrawn35
Not yet recruiting20
No longer available6
Suspended3
Enrolling by invitation2
Available2
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals82
M.D. Anderson Cancer Center73
Fred Hutchinson Cancer Center30
National Cancer Institute (NCI)27
Bristol-Myers Squibb23
National Heart, Lung, and Blood Institute (NHLBI)23
Masonic Cancer Center, University of Minnesota22
Gruppo Italiano Malattie EMatologiche dell'Adulto21
Pfizer13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive875
Leukemia, Myeloid, Acute296
Precursor Cell Lymphoblastic Leukemia-Lymphoma293
Myelodysplastic Syndromes247
Leukemia202
Leukemia, Lymphocytic, Chronic, B-Cell155
Lymphoma, Non-Hodgkin142
Hodgkin Disease131
Leukemia, Myeloid, Chronic-Phase124
Multiple Myeloma114

Trials

Showing 26 to 50 of 875. Each trial links to its page on Pharma Observatory.

775 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.